976
Index
Breastfeeding
adrenergic agonists, 456
adrenergic blocking agents, 471
anaemias, drugs used to treat, 779
anthelmintic agents, 183
antianginal agents, 717
antiarrhythmic agents, 701
antibiotics, 93
anticholinergic agents, 502
antidepressant agents, 318
antiemetic agents, 931
antifungal agents, 151
anti-infective agents, 82
anti-inflammatory agents, 241
antimigraine agents, 410
antineoplastic agents, 194
antiparkinsonism agents, 375
antiprotozoal agents, 164
antiseizure agents, 354
antiviral agents, 128
anxiolytic and hypnotic agents, 304
blood pressure, drugs affecting, 667
cardiotonic agents, 686
cholinergic agonists, 489
coagulation, drugs affecting, 752
corticosteroids, 540
diuretic agents, 807
female reproductive system, drugs
affecting, 608
gastrointestinal secretions, drugs
affecting, 899
hypoglycaemic agents, 574
hypothalamic and pituitary agents, 523
immune modulators, 260
laxatives and antidiarrhoeal agents, 917
lipid-lowering agents, 736
lower respiratory tract agents, 866
male reproductive system, drugs
affecting, 629
muscle relaxants, 386
neuromuscular junction (NMJ)
blocking agents, 435
opioids, 401
psychotherapeutic agents, 335
thyroid and parathyroid agents, 554
upper respiratory tract agents, 844
urinary tract agents, 820
Brimonidine, 956
Brinzolamide, 805, 811, 957
Bromazepan, 305, 306
Bromelain, 963
Bromhexine, 859, 860
Bromocriptine, 374–376, 521, 525, 528,
529
Brompheniramine, 852, 854
Bronchial muscle
parasympathetic blockade, effects, 505
Bronchial tree, 834, 835
Bronchiectasis, 838–839
Bronchitis, 838, 865
Bronchodilation, 469, 471
Bronchodilators/antiasthmatics, 864,
866–875
anticholinergics, 864, 867, 873–875
adverse effects, 874
care considerations, 874–875
contraindications and cautions, 874
drug–drug interactions, 874
pharmacokinetics, 873
therapeutic actions and indications,
873
sympathomimetics, 455, 864, 867,
871–873
adverse effects, 872
care considerations, 872–873
contraindications and cautions, 872
drug–drug interactions, 872
pharmacokinetics, 872
therapeutic actions and indications,
871–872
xanthines, 437, 864, 866–870
adverse effects, 869
care considerations, 869–870
contraindications and cautions,
868–869
drug–drug interactions, 869
pharmacokinetics, 868
therapeutic actions and indications,
868
Budesonide, 539, 541, 543, 847, 851,
864, 875, 877
Bulk stimulants laxatives, 916, 919, 920
adverse effects, 919
contraindications and cautions, 919
drug–drug interactions, 919
pharmacokinetics, 919
therapeutic actions and indications, 919
Bumetanide, 805, 809
Bupivacaine, 417, 425, 426
Buprenorphine, 402, 406
Bupropion, 330, 331
Burdock, 963
Buspirone, 313
Busulfan, 195, 196
Butoconazole, 157, 951
C
C fibres, 397, 398, 399
Cabazitaxel, 212, 213
Cabergoline, 374, 375, 526, 530
Caffeine, 866–869
Calamine lotion, 950
Calcipotrial, 951
Calcitonin, 551, 552, 553, 562–563, 565,
566–569
adverse effects, 568
contraindications and cautions, 568
drug–drug interactions, 568
pharmacokinetics, 568
therapeutic actions and indications, 567
Calcitonin salmon, 552, 566–569
Calcitriol, 552, 563, 565–567
Calcium channel blockers, 657, 665–666,
671–672, 714, 724–725
adverse effects, 671, 724
antianginal agents, 716, 724–725
care considerations, 672, 725
contraindications and cautions, 671,
724
drug–drug interactions, 671, 724–725
drug–food interactions, 671–672
pharmacokinetics, 671, 724
therapeutic actions and indications,
671, 724
Calcium folinate
see
Leucovorin
Calcium regulation, 562, 799
Calcium salts, 900, 904–905
Calour, 228, 232
Canagliflozin, 587, 588, 589–590
Cancer, 191–192
alternative therapies, 205
antiemetics and chemotherapy, 199
causes, 192
types of, 192
Cancer cell-specific agents, 191, 218–220
care considerations, 222
protein tyrosine kinase inhibitors, 218,
220
Candesartan, 665, 669
Candida
, 150, 151, 157
Cannabis, 67
Capacitance system, 642
Capecitabine, 200
Capillary, 642
system, 650
Capsaicin, 952
Capsicum, 963
Captopril, 657, 662, 664, 668
Carbachol, 488–490, 957
Carbamazepine, 354, 365–368
Carbapenems, 90, 97–99
adverse effects, 98
care considerations, 99
contraindications and cautions, 98
drug–drug interactions, 98
pharmacokinetics, 97–98
therapeutic actions and indications, 97
Carbetocin, 620
Carbidopa, 374–376
Carbimazole, 557, 560
Carbonic anhydrase, 794, 797
inhibitors, 803, 805, 809, 811, 813
Carboplatin, 195, 196
Carcinoma, 190
Cardiac Arrhythmia Suppression Test
(CAST), 696, 701
Cardiac conduction, 644–646
Cardiac cycle, 642, 643–644
Cardiac glycosides, 681, 685–690
adverse effects, 687
care considerations, 689–690
contraindications and cautions,
686–687
drug–drug interactions, 687–688
pharmacokinetics, 685–686
therapeutic actions and indications, 685
Cardiac output, 696, 697
Cardiomegaly, 681, 683
Cardiomyopoathy, 681, 682
Cardiotonic agents, 681–694
adults, 686
cardiac glycosides, 681, 685–690
children, 686
heart failure, 652–653, 681, 682–685
older adults, 686
phosphodiesterase inhibitors, 686,
692–693
Cardiovascular centre, 657, 658
